TY - JOUR
T1 - Coronary heart disease morbidity and mortality in hypercholesterolemic men predicted from an exercise test
T2 - The lipid research clinics coronary primary prevention trial
AU - Ekelund, Lars Göran
AU - Suchindran, Chirayath M.
AU - McMahon, Robert P.
AU - Heiss, Gerardo
AU - Leon, Arthur S.
AU - Romhilt, Donald W.
AU - Rubenstein, Carl L.
AU - Probstfield, Jeffrey L.
AU - Ruwitch, Joseph F.
PY - 1989/9
Y1 - 1989/9
N2 - A positive exercise electrocardiogram (ECG) has been proved to predict cardiovascular events in asymptomatic normolipidemic men. To study whether it is also predictive for hypercholesterolemic men, data from 3,806 asymptomatic hypercholesterolemic men in the Lipid Research Clinics Coronary Primary Prevention Trial were analyzed. All the men had performed a submaximal treadmill exercise test at baseline, before they were assigned to the cholestyramine or placebo treatment group. Because of missing or inconclusive data, 31 men were excluded from the analyses. A test was positive if the ST segment was displaced by ≥1 mm (visual code) or there was ≥10 μV-s change in the ST integral (computer code), or both. The prevalence of a positive test was 8.3%. During the 7 to 10 year (mean 7.4) follow-up period, the mortality rate from coronary heart disease was 6.7% (21 of 315) in men with a positive test and 1.3% (46 of 3,460) in men with a negative test (placebo and cholestyramine groups combined). The age-adjusted rate ratio for a positive test, compared with a negative test, was 6.7 in the placebo group and 4.8 in the cholestyramine group. With use of Cox's proportional hazards models, it was found that the risk of death from coronary heart disease associated with a positive test was 5.7 times higher in the placebo group and 4.9 times higher in the cholestyramine group after adjustment for age, smoking history, systolic blood pressure, high density lipoprotein cholesterol and low density lipoprotein cholesterol. A positive test was not significantly associated with nonfatal myocardial infarction. Thus, the results indicate that the exercise ECG response is a valuable and independent predictor of the risk of death from coronary heart disease in hypercholesterolemic men.
AB - A positive exercise electrocardiogram (ECG) has been proved to predict cardiovascular events in asymptomatic normolipidemic men. To study whether it is also predictive for hypercholesterolemic men, data from 3,806 asymptomatic hypercholesterolemic men in the Lipid Research Clinics Coronary Primary Prevention Trial were analyzed. All the men had performed a submaximal treadmill exercise test at baseline, before they were assigned to the cholestyramine or placebo treatment group. Because of missing or inconclusive data, 31 men were excluded from the analyses. A test was positive if the ST segment was displaced by ≥1 mm (visual code) or there was ≥10 μV-s change in the ST integral (computer code), or both. The prevalence of a positive test was 8.3%. During the 7 to 10 year (mean 7.4) follow-up period, the mortality rate from coronary heart disease was 6.7% (21 of 315) in men with a positive test and 1.3% (46 of 3,460) in men with a negative test (placebo and cholestyramine groups combined). The age-adjusted rate ratio for a positive test, compared with a negative test, was 6.7 in the placebo group and 4.8 in the cholestyramine group. With use of Cox's proportional hazards models, it was found that the risk of death from coronary heart disease associated with a positive test was 5.7 times higher in the placebo group and 4.9 times higher in the cholestyramine group after adjustment for age, smoking history, systolic blood pressure, high density lipoprotein cholesterol and low density lipoprotein cholesterol. A positive test was not significantly associated with nonfatal myocardial infarction. Thus, the results indicate that the exercise ECG response is a valuable and independent predictor of the risk of death from coronary heart disease in hypercholesterolemic men.
UR - http://www.scopus.com/inward/record.url?scp=0024455678&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024455678&partnerID=8YFLogxK
U2 - 10.1016/0735-1097(89)90092-2
DO - 10.1016/0735-1097(89)90092-2
M3 - Article
C2 - 2768706
AN - SCOPUS:0024455678
SN - 0735-1097
VL - 14
SP - 556
EP - 563
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 3
ER -